These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29102116)

  • 1. Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22Ξ”ler) vaccine strain.
    Byrd W; Ruiz-Perez F; Setty P; Zhu C; Boedeker EC
    Vet Microbiol; 2017 Nov; 211():180-188. PubMed ID: 29102116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
    Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A directed intimin insertion mutant of a rabbit enteropathogenic Escherichia coli (REPEC) is attenuated, immunogenic and elicits serogroup specific protection.
    Ahmed S; Byrd W; Kumar S; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):146-55. PubMed ID: 23084628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain.
    Zhu C; Feng S; Thate TE; Kaper JB; Boedeker EC
    Vaccine; 2006 May; 24(18):3845-55. PubMed ID: 16112258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.
    Zhu C; Feng S; Yang Z; Davis K; Rios H; Kaper JB; Boedeker EC
    Vaccine; 2007 Feb; 25(10):1884-92. PubMed ID: 17234305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.
    Lu X; Skurnik D; Pozzi C; Roux D; Cywes-Bentley C; Ritchie JM; Munera D; Gening ML; Tsvetkov YE; Nifantiev NE; Waldor MK; Pier GB
    mBio; 2014 Mar; 5(2):e00974-14. PubMed ID: 24667709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin.
    Agin TS; Zhu C; Johnson LA; Thate TE; Yang Z; Boedeker EC
    Infect Immun; 2005 Oct; 73(10):6608-19. PubMed ID: 16177337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated].
    Liu J; Sun Y; Feng SZ
    Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
    Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
    Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and immunization of an attenuated vaccine candidate enteropathogenic Escherichia coli O45 ].
    Hu Y; Song J; Zhao B
    Sheng Wu Gong Cheng Xue Bao; 2009 Feb; 25(2):181-8. PubMed ID: 19459321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of live attenuated bacterial vaccines targeting Escherichia coli heat-labile and heat-stable enterotoxins.
    Zhu C; Setty P; Boedeker EC
    Vet Microbiol; 2017 Apr; 202():72-78. PubMed ID: 28527491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
    Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
    Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2.
    Tsuji T; Shimizu T; Sasaki K; Tsukamoto K; Arimitsu H; Ochi S; Shimizu T; Taniguchi K; Noda M; Neri P; Mori H
    Vaccine; 2008 Apr; 26(17):2092-9. PubMed ID: 18387720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.
    Zhu C; Yu J; Yang Z; Davis K; Rios H; Wang B; Glenn G; Boedeker EC
    Clin Vaccine Immunol; 2008 Feb; 15(2):359-66. PubMed ID: 18003816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli.
    Won G; Kim TH; Lee JH
    BMC Vet Res; 2017 Feb; 13(1):40. PubMed ID: 28143511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector.
    Keller R; Hilton TD; Rios H; Boedeker EC; Kaper JB
    Microb Pathog; 2010 Jan; 48(1):1-8. PubMed ID: 19878715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
    Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
    Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.
    Buddenborg C; Daudel D; Liebrecht S; Greune L; Humberg V; Schmidt MA
    Int J Med Microbiol; 2008 Jan; 298(1-2):105-14. PubMed ID: 17936683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
    Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X
    Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.